🇺🇸 FDA
Pipeline program

Injectable suspension of allogeneic adult mesenchymal stem cells

HidraQureS/2020

Phase 2 mab active

Quick answer

Injectable suspension of allogeneic adult mesenchymal stem cells for Hidradenitis Suppurativa is a Phase 2 program (mab) at Lxo Ireland Designated Activity Company with 1 ClinicalTrials.gov record(s).

Program details

Company
Lxo Ireland Designated Activity Company
Indication
Hidradenitis Suppurativa
Phase
Phase 2
Modality
mab
Status
active

Clinical trials